HIGHLIGHTS
- who: Shao-Jun Zhang from the study in East ChinaDepartment of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University have published the paper: Effectiveness and safety of bedaquiline-containing regimens for treatment on patients with refractory RR/MDR/XDR-tuberculosis: a retrospective cohort study in East China, in the Journal: (JOURNAL)
- what: This study showed that patients receiving BDQcontaining regimens in this study had higher culture conversion rates at month 6 (90.2% vs. 72.0%) and treatment success rates (92.2% vs. 63.0%) than those receiving BDQ-free regimens. In the present study, the data . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.